Peptide Antibiotics

Peptide antibiotics for sepsis treatment (IV) : ADT-117, ADT-337 and ADT-340
```
**① Unmet medical needs and First-in-class**

**② Fast Tract**
```

(Available for sale after phase II clinical trial)

   **③ In vivo efficacy and toxicity validation**

(ADT-340 and ADT-117)

   **(ADT-117 by CRO company)**

  **④ Indication : Sepsis**

  **⑤ Target : Gram negative bacteria and MDR bacteria**

Peptide Antibiotics for skin treatment : ADT-338, 340

① Unmet medical needs and First-in-class

② In vivo efficacy and in vitro toxicity validation

  **(ADT-338 and ADT-340)**

 **③ Indications: Foot Ulcer and Wound**

 **(Skin treatment by patch loaded with the peptide)**